Speakers

The human skin, functioning as a large-area, multi-point, multi-modal, and flexible sensor, serves as inspiration for the development of electronic skin in robots, aimed at detecting pressure and thermal patterns simultaneously. With advancements in flexibility, electronic skin has transcended its initial use in robotics and expanded into next-generation wearable technologies for humans. This evolution has now reached a stage where ultra-thin semiconductor membranes can be directly attached to the skin. This seamless integration of electronics with human skin allows for continuous health monitoring over prolonged periods, facilitating personalized medical care. The ultimate goal of electronic skin is to non-invasively capture human activities in natural settings, fostering interactive synergy between electronic and human skin. In this presentation, I will discuss recent advancements in stretchable thin-film electronics, focusing on their applications in robotics and next-generation healthcare wearables. I will also address the challenges faced in this field and highlight the potential future prospects of electronic skin.

Rechargeable batteries have been an integral part of the portable electronics revolution and are now playing a critical role in transport and grid applications to help mitigate climate change. However, these applications come with different sets of challenges. New technologies are being investigated and fundamental science is key to producing non-incremental advances and to develop new strategies for energy storage and conversion.
This talk will focus on our own work to develop NMR, MRI and new optical methods that allow devices to be probed while they are operating, from the local, to particle and then cell level. This allows transformations of the various cell materials to be followed under realistic conditions without having to disassemble and take apart the cell. Starting with local structure and dynamics, as measured by NMR, I will then show - with new optical methods - how the different dynamics can result in different intercalation mechanisms. A good example is our work on LiCoO2, where via optical approaches we were able to directly visualize movement of phase fronts as lithium is removed and inserted into this material. New results on solution-based redox flow and extremely high-rate batteries will be outlined; I will then illustrate how our new metrologies can be extended to study a wider range of electrochemical systems.

Mesothelioma Research & Treatment in Europe/United Kingdom
Prof Paul Baas has been interested in mesothelioma for many years. He has focused on translational research. He participated in many clinical studies and was the first author of the practice changing study of IO combination in mesothelioma. He has published over 350 paper and is currently focusing on the supportive care of patients with mesothelioma in The Netherlands. He is currently the chairperson for the Rare Tumors group of the IASLC and has functioned in the iMig for many years as board member.

Dr. Mansfield is a medical oncologist at Mayo Clinic with a focus on thoracic malignancies and early therapeutics. He is the Chair of the Mayo Clinic Comprehensive Cancer Center's Thoracic Malignancies Disease Group and Data Safety Monitoring Committee. His work has supported multiple approvals by the FDA for the treatment of lung cancers, mesothelioma and thyroid cancers. His research has been supported by the NCI, DoD, Mark Foundation, Thymic Carcinoma Center and others.

The human skin, functioning as a large-area, multi-point, multi-modal, and flexible sensor, serves as inspiration for the development of electronic skin in robots, aimed at detecting pressure and thermal patterns simultaneously. With advancements in flexibility, electronic skin has transcended its initial use in robotics and expanded into next-generation wearable technologies for humans. This evolution has now reached a stage where ultra-thin semiconductor membranes can be directly attached to the skin. This seamless integration of electronics with human skin allows for continuous health monitoring over prolonged periods, facilitating personalized medical care. The ultimate goal of electronic skin is to non-invasively capture human activities in natural settings, fostering interactive synergy between electronic and human skin. In this presentation, I will discuss recent advancements in stretchable thin-film electronics, focusing on their applications in robotics and next-generation healthcare wearables. I will also address the challenges faced in this field and highlight the potential future prospects of electronic skin.

Rechargeable batteries have been an integral part of the portable electronics revolution and are now playing a critical role in transport and grid applications to help mitigate climate change. However, these applications come with different sets of challenges. New technologies are being investigated and fundamental science is key to producing non-incremental advances and to develop new strategies for energy storage and conversion.
This talk will focus on our own work to develop NMR, MRI and new optical methods that allow devices to be probed while they are operating, from the local, to particle and then cell level. This allows transformations of the various cell materials to be followed under realistic conditions without having to disassemble and take apart the cell. Starting with local structure and dynamics, as measured by NMR, I will then show - with new optical methods - how the different dynamics can result in different intercalation mechanisms. A good example is our work on LiCoO2, where via optical approaches we were able to directly visualize movement of phase fronts as lithium is removed and inserted into this material. New results on solution-based redox flow and extremely high-rate batteries will be outlined; I will then illustrate how our new metrologies can be extended to study a wider range of electrochemical systems.

Mesothelioma Research & Treatment in Europe/United Kingdom
Prof Paul Baas has been interested in mesothelioma for many years. He has focused on translational research. He participated in many clinical studies and was the first author of the practice changing study of IO combination in mesothelioma. He has published over 350 paper and is currently focusing on the supportive care of patients with mesothelioma in The Netherlands. He is currently the chairperson for the Rare Tumors group of the IASLC and has functioned in the iMig for many years as board member.

Dr. Mansfield is a medical oncologist at Mayo Clinic with a focus on thoracic malignancies and early therapeutics. He is the Chair of the Mayo Clinic Comprehensive Cancer Center's Thoracic Malignancies Disease Group and Data Safety Monitoring Committee. His work has supported multiple approvals by the FDA for the treatment of lung cancers, mesothelioma and thyroid cancers. His research has been supported by the NCI, DoD, Mark Foundation, Thymic Carcinoma Center and others.